Navigation Links
Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
Date:6/4/2013

is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections. It is focused on developing and commercializing innovative diagnostic systems for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company's revolutionary BACcel™ platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity.   In addition to the BACcel system development pipeline, the Company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.  The Company's website address is www.acceleratediagnostics.com.

Forward-Looking Statements

This press release contains words such as "expects," "shall," "will," "believes" and other similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.  Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements.  For a full discussion of the Company's risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in Item 1A in the Company's Transition Report on Form 10-KT, filed with the SEC on March 20, 2013.  In addition, the
'/>"/>

SOURCE Accelerate Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. ZyDoc Selects Health Fidelitys REVEALâ„¢ Natural Language Processing (NLP) Platform to Accelerate Time to Value for its MediSapien Web Services
4. Berg Pharma and the Parkinsons Institute ink R&D collaboration to drive disease understanding and accelerate therapeutic and diagnostic development in Parkinsons Disease
5. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
6. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
7. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
8. Medical Devices Market in China to 2018 - Government Reforms Aimed at Strengthening the Healthcare System and Expanding Access will Accelerate Growth
9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
10. Emerging Pharmaceutical Market in South Africa - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
11. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... Sept. 29, 2011 A west coast secret is finally ... the way from Beverly Hills, California, a health and beauty ... ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is helping ... in less than 4 weeks of use.  Just a few ...
... Sept. 29, 2011 Terumo Americas Holdings, Inc., a ... anniversary of Terumo Corporation,s founding in 1921.  Terumo Corporation ... with $4 billion in annual sales and operations in ... Forbes magazine ranked Terumo Corporation 14th of the ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 2Terumo Corporation, A Global Leader In Medical Device Technology, Celebrates 90th Anniversary 3
(Date:4/24/2014)... substantial proportion of risk for developing autism spectrum disorders ... interconnected biological pathways, according to researchers from the Icahn ... broad study of almost 2,500 families in the United ... "Convergence of Genes and Cellular Pathways Dysregulated in Autism ... American Journal of Human Genetics on April 24. ...
(Date:4/24/2014)... Scientific research at UT Southwestern Medical Center previously ... completely, whereas the adult heart lacks this ability. New ... the heart loses its incredible regenerative capability in adulthood, ... , Yes, oxygen. It is well-known that a major ... throughout the body. But at the same time, oxygen ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
Breaking Medicine News(10 mins):Health News:Genetic alterations in shared biological pathways as major risk factor for ASD 2Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... Their growths also tend to be on the right side, requiring ... -- Among Hispanics, men are twice as likely as women to ... polyps, a new study in Puerto Rico has found. , The ... 56 percent more likely to have polyps than those younger than ...
... ... endometriosis, diagnosis and treatment options. , ... (PRWEB) May 2, 2010 -- The Endometriosis Foundation of America (EFA) ... Science of Endometriosis: Stem Cells to Radical Excision Surgery”, taking place in New York ...
... VANCOUVER, BRITISH COLUMBIA Reports have suggested that sleep ... (ASDs) are associated with challenging daytime behaviors. ... with ASD confirms these reports and will support the ... to improve behavior, according to researchers from Autism Speaks, ...
... ask children to fast overnight before a cholesterol test. New ... "Cholesterol testing can be very difficult for families," said Asheley ... presented Sunday, May 2 at the Pediatric Academic Societies (PAS) ... fast, this almost always means the child has to return ...
... majority of teens say they have never heard of acetaminophen ... with access to the label instructions despite having taken ... Medical Center Study assessing teens, health literacy. More than 60 ... heard of acetaminophen despite 21 percent of them having taken ...
... include Tylenol, Tylenol Plus, Motrin and Benadryl , SATURDAY, ... Friday recalled more than 40 of its liquid cold ... medications may not meet federal quality standards. , The ... Plus, Motrin, Zyrtec and Benadryl. These medications have been ...
Cached Medicine News:Health News:Colon Polyps More Common in Hispanic Men Than Women 2Health News:Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC 2Health News:Children may be able to eat before cholesterol test, study shows 2
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: